Past infections have long-term effects on liver immune cells 

Many infections affect the liver, yet little is known about the long-term impact of these infections on the liver’s immune cells. Now, a study by the teams of Prof. Jo Van Ginderachter (VIB-VUB) and Prof Kiavash Movahedi at VUB reveals long-lasting changes in the liver’s Kupffer cells following an infection. The work appears in the Journal of Hepatology

The role of Kupffer cells 

Our immune system is a complex network of cells and molecules that work together to protect our bodies from harmful invaders like bacteria, viruses, and parasites. Among the key players in this defense system are macrophages, specialized immune cells that act as the first line of defense against infections. In the liver, a vital organ responsible for filtering, a specific type of macrophage called Kupffer cells plays a crucial role in monitoring the blood for pathogens. 

Yet, the long-term effects of infections on the liver immune cells, including Kupffer cells, are unknown. Researchers from the lab of Prof. Jo Van Ginderachter at the VIB Center for Inflammation Research and Prof Kiavash Movahedi at VUB, with colleagues from UGent and the VIB Single Cell Core studied the lingering effects of infection with the parasite Trypanosoma brucei brucei on the liver immune cells (in a mouse model for human sleeping sickness). 

The research team, with Prof. Jo Van Ginderachter in the center.

A lasting mark 

By using cutting-edge techniques such as fate mapping, single-cell sequencing, and epigenetic analysis, the researchers – led by PhD student Mohamed Amer Musrati and Dr. Benoit Stijlemans – acquired a detailed look at the changes in the liver following infection. 

They found that Trypanosoma infections strongly alter the composition of macrophages in the liver, identifying several newly recruited populations that altered their gene expression to fight the infection. Remarkably, after the infection is cleared, the Kupffer Cells bear long-lasting changes in the accessibility and expression of certain genes, highlighting the enduring impact of past infections on our immune system. 

Importantly, the mice who had gone through an earlier infection were more resilient to a subsequent infection with another pathogen, which suggests that an infection reprograms the liver’s Kupffer cells to better fight future infections. In other words, our infection history may influence the way we can deal with future infections due to macrophage reprogramming. ​ 

Prof. Jo Van Ginderachter says, “By unraveling the long-term effects of infections on liver macrophages, this study opens up new avenues for understanding and treating infectious diseases.” 

Funding 

This work was supported by FWO, ERC, an iBOF research consortium, and the European Regional Development Fund (ERDF). 

Publication 

Infection history imprints prolonged changes to the epigenome, transcriptome, and function of Kupffer Cells. Musrati, Stijlemans, et al. Journal of Hepatology, 2024. 


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be